DFX Intelligence
Private Credit Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
1•••••• B• L••
Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: Fixed Rate; Pharmaceuticals
Principal held
at least $90.6M
sum of BDC pieces, a lower bound
Fair value
$89.2M
99c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
3
3 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Oct 8, 2030
no dated debt inside 24 months
On the tape since
Mar 31, 2025
latest Jun 30, 2026
Events
2
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $59.3M | 98c | SOFR+625 bp | Oct 8, 2030 | 3 |
| notes lien unstated | at least $31.3M | 101c | 10.00% | Apr 15, 2032 | 2 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| O•••••• S•••••••• L•••••• C••• | notes lien unstated Bond | $9.1M | $9.2M 101c | 10.00% |
| O•••••• S•••••••• L•••••• C••• | term loan first lien First Lien Term Loan | $9.5M | $9.2M 99c | S+625 bp |
| O•••••• S•••••••• C••••• F••• | term loan first lien First Lien Term Loan | $27.4M | $26.7M 99c | S+625 bp |
| O•••••• S•••••••• C••••• F••• | notes lien unstated Fixed Rate Bond | $22.2M | $22.5M 101c | 10.00% |
| S••••• P•••• S•••••••• L•••••• F••• | term loan first lien 1st Lien/Secured Loans Instrument 1st Lien Term Loan Industry Healthcare Equipment & Suppl | $22.4M | $21.7M 97c | SOFR+625 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 3 | $90.6M | $89.2M | 99c | 0 |
| Mar 31, 2026 | 3 | $90.7M | $89.5M | 100c | 0 |
| Dec 31, 2025 | 3 | $121M | $120M | 101c | 0 |
| Sep 30, 2025 | 3 | $121M | $121M | 101c | 0 |
| Jun 30, 2025 | 2 | $98.7M | $96.7M | 100c | 0 |
| Mar 31, 2025 | 2 | $98.7M | $96.1M | 99c | 0 |
What changed
- Maturity shortened (observed)Mar 31, 2026
- Maturity extended (observed)Dec 31, 2025
- Maturity extended (observed)Dec 31, 2025
- New lender joined a facilitySep 30, 2025
- New borrower on a BDC scheduleMar 31, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- 1•••••• B•derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 3 BDCsderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it